Novartis sues FDA over its stance on Sanofi blockbuster’s exclusivity

[cafead]

via Novartis’ generic drug subsidiary Sandoz has sued the FDA, claiming the agency is wrongly protecting Sanofi’s blockbuster multiple sclerosis drug Aubagio from generic competition.

article source